Dermapharm Holding SE (STU:DMP) PB Ratio : 3.33 (As of Jun. 22, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dermapharm Holding SE PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-22), Dermapharm Holding SE's share price is €36.00. Dermapharm Holding SE's Book Value per Share for the quarter that ended in Mar. 2024 was €10.81. Hence, Dermapharm Holding SE's PB Ratio of today is 3.33.

The historical rank and industry rank for Dermapharm Holding SE's PB Ratio or its related term are showing as below:

STU:DMP' s PB Ratio Range Over the Past 10 Years
Min: 2.93 Med: 6.65 Max: 19.43
Current: 3.35

During the past 11 years, Dermapharm Holding SE's highest PB Ratio was 19.43. The lowest was 2.93. And the median was 6.65.

STU:DMP's PB Ratio is ranked worse than
74% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.895 vs STU:DMP: 3.35

During the past 12 months, Dermapharm Holding SE's average Book Value Per Share Growth Rate was 0.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 18.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 19.30% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Dermapharm Holding SE was 83.20% per year. The lowest was 18.80% per year. And the median was 37.60% per year.

Back to Basics: PB Ratio

Dermapharm Holding SE PB Ratio Historical Data

The historical data trend for Dermapharm Holding SE's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dermapharm Holding SE PB Ratio Chart

Dermapharm Holding SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

7.71

9.61

9.67

3.80

4.24

Dermapharm Holding SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PB Ratio	Get a 7-Day Free Trial															3.48	4.66	3.86	4.24	3.05

Competitive Comparison of Dermapharm Holding SE's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dermapharm Holding SE's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's PB Ratio distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's PB Ratio falls into.

Dermapharm Holding SE PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Dermapharm Holding SE's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Mar. 2024)
	=	36.00	/	10.808
	=	3.33

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Dermapharm Holding SE (STU:DMP) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Dermapharm Holding SE PB Ratio Related Terms

Thank you for viewing the detailed overview of Dermapharm Holding SE's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Dermapharm Holding SE (STU:DMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dermapharm Holding SE (STU:DMP) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

0A5J:UK DMP:Germany

Address

Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031

Website

https://www.dermapharm.de

Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs and natural remedies. Its portfolio of products includes cosmetics, nutritional supplements and diet and medical devices. Business operating segments include Branded pharmaceuticals and other healthcare products which drive key revenue, Herbal extracts and Parallel import business. Branded pharmaceuticals and other healthcare products focus on the development, manufacturing and marketing of branded pharmaceuticals and other healthcare products. Herbal extracts include the manufacturing of phytopharmaceuticals, nutraceuticals and cosmetics products. Parallel import brands business operates under the AxiCorp brand.

Dermapharm Holding SE (STU:DMP) Headlines

No Headlines